HLA association with hepatitis C virus infection

Human Immunology

Volumn 61, Issue 3, 2000, Pages 348-353

  Vejbaesya, Sasijit ^a   Songsivilai, Sirirurg ^b   Tanwandee, Taweesak ^b   Rachaibun, Sirinuch ^a   Chantangpol, Rapeepan ^a   Dharakul, Tararaj ^b  

^a Fac Med   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Hepatitis C; HLA

Indexed keywords

HEPATITIS C ANTIBODY; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; FEMALE; HEPATITIS C; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; LYMPHOCYTOTOXICITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THAILAND;

DISEASE SUSCEPTIBILITY; FEMALE; HEPATITIS C; HEPATITIS C, CHRONIC; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-D ANTIGENS; HUMANS; MALE; PHENOTYPE; THAILAND;

EID: 0033993665     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(99)00131-7     Document Type: Article

References (21)

1. Chinuvati T, Poovorawan Y, Luengrojanakul P: The prevalence of hepatitis C virus antibody in high risk groups of Thai children and adults. Gastroenterol Jpn 26(Suppl. 3):176, 1991.
2. Boonmar S., Pojanagaroon B., Watanabe Y., Tanaka Y., Saito I., Miyamura T. Prevalence of hepatitis C virus antibody among healthy blood donors and non-A, non-B hepatitis patients in Thailand. Jpn J Med Sci Biol. 43:1990;29.
3. Tong M.J., El-Farra N.S., Reikes A.R., Co R.L. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med. 332:1995;1463.
4. Songsivilai S., Dharakul T., Kanistanon D. Hepatitis C virus genotypes in patients with hepatocellular carcinoma and cholangiocarcinoma in Thailand. Trans Roy Soc Trop Med Hyg. 90:1996;505.
5. Alberti A., Morsica G., Chemello L., Cavalletto D., Noventa F., Pontisso P., Ruol A. Hepatitis C vieaemia and liver disease in symptom-free individuals with anti-HCV. Lancet. 340:1992;697.
6. Brillanti S., Foli M., Gaiani S., Masci C., Miglioli M., Barbara L. Persistent hepatitis C viraemia without liver disease. Lancet. 341:1993;464.
7. Houghton M. Hepatitis C viruses. Fields B.N., Knipe D.M., Howley P.M. Fields Virology (3rd ed). 1996;Lippincott-Raven, Philadelphia.
8. Imanishi T., Akaza T. Disease component. Tsuji K., Aizawa M., Sasazuki T. HLA 1991 Proceedings of the Eleventh International Workshop and Conference, Vol. 1 . 1991;772 U.K. Oxford University Press, Oxford.
9. Peano G., Menardi G., Ponzetto A., Fenoglio L. HLA-DR5 antigen a genetic factor influencing the outcome of hepatitis C virus infection . Arch Intern Med. 154:1994;2733.
10. Alric L., Fort M., Izopet J., Vinel J.P., Charlet J.P., Selves J., Purl J., Pascal J.P., Duffnut M., Abbal M. Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection. Gastroenterology. 113:1997;1675.
11. Minton E.J., Smillie D., Neal K.R., Irving W.L., Underwood J.C.E., James V. Association between MHC class II alleles and clearance of circulating hepatitis C virus. J Infect Dis. 178:1998;39.
12. Hohler T., Gerken G., Notghi A., Knolle P., Lubjuhn R., Taheri H., Schneider P., Meyer zum Buschenfelde K.H., Rittner C. MHC class II genes influence the susceptibility to chronic hepatitis C. Hum Immunol. 47:1996;123.
13. Kuzushita N., Hayashi N., Moribe T., et al. Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus. Hepatology. 27:1998;240.
14. Songsivilai S., Kanistanon D., Panyavinin W., Neelamek M., Dharakul T. Improved amplification system for detection of hepatitis C virus genome that simultaneously differentiated virus genotypes. Southeast Asian J Trop Med Pub Health. 27:1996;237.
15. Chandanayingyong D., Stephens H.A.F., Klaythong R., Sirikong M., Udee S., Longta P., Chantangpol R., Bejrachandra S., Rungruang E. HLA-A, -B, -DRB1, -DQA1, and -DQB1 polymorphism in Thais. Hum Immunol. 53:1997;174.
16. Woolf B. On estimating the relation between bloods and disease. Ann Hum Genet. 19:1995;251.
17. Botarelli P., Brunetto M.R., Minutello M.A., Calvo P., Unutmaz D., Weiner A.J., Choo Q.L., Shuster J.R., Kuo G., Bonino F. T-lymphocyte response to hepatitis C virus in different clinical courses of infection. Gastroenterology. 104:1993;580.
18. Chang K.M., Rehermann B., Chisari F.V. Immunopathology of hepatitis C. Springer Semin Immunopathol. 19:1997;57.
19. Verdon R., Pol S., Landais P., et al. Absence of association between HLA antigens and chronicity of viral hepatitis in haemodialyzed patients. J Hepatol. 21:1994;388.
20. Chen D.F., Endress W., Kliem V., et al. No significant influence of HLA determinants on susceptibility to hepatitis C virus infection in Caucasian patients with end-stage renal disease. Liver. 16:1996;384.
21. Tibbs C., Donaldson P., Underhill J., Thomson L., Manabe K., Williams R. Evidence that the HLA DQA1*03 allele confers protection from chronic HCV infection in Northern European Caucasoids. Hepatology. 24:1996;1342.